Advair hfa and Peripheral arterial occlusive disease - a phase IV clinical study of FDA data

Summary:

Peripheral arterial occlusive disease is reported as a side effect among people who take Advair hfa (fluticasone propionate; salmeterol xinafoate), especially for people who are female, 60+ old, have been taking the drug for 5 - 10 years also take Ventolin, and have Multiple allergies.

The phase IV clinical study analyzes which people have Peripheral arterial occlusive disease when taking Advair hfa. It is created by eHealthMe based on reports of 69,236 people who have side effects when taking Advair hfa from the FDA, and is updated regularly.

What is Advair hfa?

Advair hfa has active ingredients of fluticasone propionate; salmeterol xinafoate. It is often used in asthma. eHealthMe is studying from 69,790 Advair hfa users. Check the latest studies of Advair hfa.

What is Peripheral arterial occlusive disease?

Peripheral arterial occlusive disease (reproducible ischemic muscle pain) is found to be associated with 537 drugs and 682 conditions by eHealthMe. Check the latest studies of Peripheral arterial occlusive disease.

On Jul, 21, 2026

69,236 people reported to have side effects when taking Advair hfa.
Among them, 29 people (0.04%) have Peripheral arterial occlusive disease.

Could Advair hfa cause Peripheral arterial occlusive disease?

Among these 29 people:

How long have people been on Advair hfa when they have Peripheral arterial occlusive disease? *

What is the gender of people who have Peripheral arterial occlusive disease when taking Advair hfa? *

female: 64 %
male: 36 %

What is the age of people who have Peripheral arterial occlusive disease when taking Advair hfa? *

What are other drugs people take besides Advair hfa? *

What are other side effects people have besides Peripheral arterial occlusive disease? *

Dyspnea (difficult or laboured breathing): 15 people, 51.72%
Loss Of Consciousness: 10 people, 34.48%
Fatigue (feeling of tiredness): 9 people, 31.03%
Cough: 9 people, 31.03%
Fall: 9 people, 31.03%
Gait Disturbance: 7 people, 24.14%
Headache (pain in head): 7 people, 24.14%
Osteoporosis (bones weak and more likely to break): 7 people, 24.14%
Head Injury: 7 people, 24.14%
Productive Cough: 7 people, 24.14%

What are the existing conditions these people have? *

Multiple Allergies (allergy to multiple agents): 6 people, 20.69%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 4 people, 13.79%
Weight Loss: 2 people, 6.90%
Depression: 2 people, 6.90%
Dyspnea (difficult or laboured breathing): 2 people, 6.90%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 2 people, 6.90%
Bronchitis Chronic (inflammation of the mucous membrane in the bronchial tubes- chronic): 2 people, 6.90%
High Blood Cholesterol: 2 people, 6.90%
High Blood Pressure: 2 people, 6.90%
Impaired Gastric Emptying: 2 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Advair hfa and have Peripheral arterial occlusive disease?

- Check whether Peripheral arterial occlusive disease is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Advair hfa:

Advair hfa (69,790 reports)

Peripheral arterial occlusive disease treatments and more:

Peripheral arterial occlusive disease (9,473 reports)

How severe was Peripheral arterial occlusive disease and when was it recovered:

Peripheral arterial occlusive disease in Advair hfa

Expand to all the drugs that have ingredients of fluticasone propionate; salmeterol xinafoate:

Peripheral arterial occlusive disease and drugs with ingredients of fluticasone propionate; salmeterol xinafoate (77 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Advair hfa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Peripheral arterial occlusive disease:

Peripheral arterial occlusive disease (537 drugs)

Browse all the conditions that are associated with Peripheral arterial occlusive disease:

Peripheral arterial occlusive disease (682 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fluticasone propionate; salmeterol xinafoate (the active ingredients of Advair hfa) and Advair hfa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.